Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,025 public trials 2,027 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Ibrutinib and Standard Immuno-Chemotherapy in Younger, High-Risk Patients With Diffuse Large B-Cell Lymphoma

NCT03399513

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: HELIOS Hospital Berlin-Buch Berlin, Germany

Hospital Chemnitz Chemnitz, Germany

University Hospital Cologne Cologne, Germany

University Hospital Göttingen Göttingen, Germany

View Trial Details

Completed

PD1-CD19-CART in Patients With r/r B-cell Lymphoma

NCT04213469

Conditions: B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: The First Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, Zhejiang, China

View Trial Details

Completed

Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile

NCT01454297

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Mayo Clinic Campus in Scottsdale, AZ Scottsdale, Arizona, United States

UC San Diego Moores Cancer Center San Diego, California, United States

Sharp Health Care San Diego, California, United States

VA San Diego Healthcare System San Diego, California, United States

View all 73 locations

View Trial Details

Completed

A Roll-over Study to Provide Continued Treatment With Lyophilized Pegaspargase (S95014) in Pediatric Patients With Acute Lymphoblastic Leukemia (ALL)

NCT04956666

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Regional Children Clinical Hospital Chelyabinsk, Russia

Children Regional Clinical Hospital Krasnodar, Russia

Russian Children Clinical Hospital Moscow, Russia

Regional Children Hospital Nizhny Novgorod, Russia

View Trial Details

Completed

Comparing Autologous Peripheral Blood Stem Cell to Bone Marrow Transplantation for Recurrent Non-Hodgkin's Lymphoma

NCT00574626

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations: University of Nebraska Medical Center Omaha, Nebraska, United States

View Trial Details

Completed

Gossypol Acetic Acid With Lenalidomide and Dexamethasone in Treating Patients With Relapsed Symptomatic Multiple Myeloma

NCT02697344

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Mayo Clinic in Florida Jacksonville, Florida, United States

View Trial Details

Completed

A Study Comparing SIBP-02 and Rituximab Combination With CHOP in Previously Untreated Subjects With CD20+ DLBCL

NCT04361279

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: The First Affiliated Hospital of College of Medicine, Zhejiang University Hangzhou, China

View Trial Details

Completed

Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma

NCT00004192

Conditions: Agranulocytosis, Blood Protein Disorders, Burkitt Lymphoma, +42 more
Locations: Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States

University of Nebraska Medical Center Omaha, Nebraska, United States

Ireland Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Stage III or Stage IV Non-Hodgkin's Lymphoma

NCT00004198

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: University of Nebraska Medical Center Omaha, Nebraska, United States

View Trial Details

Completed

Monoclonal Antibody Therapy in Relapsed Non-Hodgkin's After Chemotherapy and Autologous Stem Cell Transplantation

NCT00031642

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +28 more
Locations: Eppley Cancer Center at University of Nebraska Medical Center Omaha, Nebraska, United States

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions